ENDODERMA CO.,LTD. is the edge leader in functional cosmetics based in microneedle technologies, and promising bio-venture company specialized in Transdermal Drug Delivery System (TDDS). Besides the painful ingections, it has been difficult to deliver active and functional ingredients effectively into the skin where most important skin cells exist. We have strived to develop the TDDS which makes it possible to deliver ingredients without pain, necessary presence of medical staffs and medical waste. We have successfully developed the genuine microstructure that makes a breakthrough for active skin care and drug delivery.
ENDODERMA has successfully developed the proprietary genuine microstructure. We provide the dermatological platform based on the innovative TDDS. We will keep striving to develop edge TDDS platform for high-end functional cosmetics and a safer and easier delivery of active ingredients, wave, and even frequencies for electroceuticals. Further, Endoderma will build edge platforms not just for inward transdermal delivery but also for outward solutions for real-time bio-sensing, sampling, and digital bio-markers.
The Edge Leader in TDDS and Microneedle Patches
||Major business||TDDS(MicroNeedle cosmetics & bio)
Proprietary ingredients & supplements
|CEO||Sang Yoon BAE(Mr.)
||IP||MN Structure, CLHA, Dissolving HA Micro Structrue, and others.
|Establishment||Jan. 9th, 2015
||Factory||Ohsong, Choongchung Bukdo, South Korea
|Address||Suite 201, C's Tower, 58 Pankyo-ro 255,
Bundang-gu, Seongnam-si, South Korea
SuHeung(KOSPI Listed, Market Cap. US$ 510M) and Yuhan(KOSPI Listed, Market Cap. US$ 3.7B) are the major investors of NaturalEndo Tech(KOSDAQ Listed, Market Cap. US$ 120M) which is the biggest share holder of EndoDerma
Functional cosmetics approval by MFDS
Launched NEEDLY in Watsons Thailand
Launched Skincare brand NEEDLY
Microneedle Patch launched at Japan, Austria, Mexico
Germany Douglas and Sephora
Overnight Micro Patch, 3 Patent registration in Korea
Established Endoderma Co., LTD
ENDODERMA Possesses the genuine microstructure based on proprietary transdermal drug delivery system (TDDS)
Developing derma and cosmeceuticals
1 Delivery of bio-active substances deep into skin
2 TDDS with high delivery rate of active ingredients
3 Application of gel type crossed-linked HA
1 New dermatological solutions for various skin troubles
2 Specific spot cares on customer's needs
over 80% delivery rate
It increases the delivery rate of active ingredients and intensively manages the skin.
Creative microneedle shape and CLHA application
Completion of safety efficacy clinical test
Automated manufacturing equipment ISO22716 and Cosmetics GMP Facilities
Custom-made microneedle patch
Self R&D. OEM/ODM production with proprietary technology
Best Quality Control and Quality Assurance system
Endoderma meets various customers' needs by providing the cutting-edge products that are strictly quality-controlled and quality-assured through the entire manufacturing process. Among others, a vision inspection system enables the completion of the state-of-the-art technology.
product type and